Concepedia

Publication | Closed Access

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease

DOI

105

Citations

17

References

2016

Year

Stuart M. Sprague, Paul W. Crawford, Joel Z. Melnick, Stephen A. Strugnell, Shaukat Ali, Roberto Mangoo‐Karim, Sungchun Lee, P. Martin Petkovich, Charles W. Bishop
American Journal of Nephrology

Abstract

Oral ER calcifediol is safe and effective in treating SHPT and vitamin D insufficiency in CKD.

References

YearCitations

Page 1